Shares of Loncar China BioPharma ETF (NASDAQ:CHNA – Get Rating) shot up 5.2% during trading on Friday . The company traded as high as $18.54 and last traded at $18.54. 310 shares were traded during trading, a decline of 59% from the average session volume of 764 shares. The stock had previously closed at $17.63.
Loncar China BioPharma ETF Stock Performance
The stock’s 50 day moving average is $19.33 and its 200 day moving average is $18.13.
Institutional Trading of Loncar China BioPharma ETF
An institutional investor recently bought a new position in Loncar China BioPharma ETF stock. OLD Mission Capital LLC purchased a new stake in shares of Loncar China BioPharma ETF (NASDAQ:CHNA – Get Rating) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 4,620 shares of the company’s stock, valued at approximately $87,000. OLD Mission Capital LLC owned approximately 1.54% of Loncar China BioPharma ETF at the end of the most recent quarter.
Loncar China BioPharma ETF Company Profile
The Loncar China BioPharma ETF (CHNA) is an exchange-traded fund that is based on the Loncar China BioPharma index. The fund tracks a tier-weighted index of companies directly involved in the growth of Chinas pharmaceutical and biotech industry. CHNA was launched on Aug 14, 2018 and is managed by Loncar.
Recommended Stories
- Get a free copy of the StockNews.com research report on Loncar China BioPharma ETF (CHNA)
- Costco Sales Disappoint, Markets Are Missing This Upside Driver
- First Republic Bank Is A Speculative Play, Here’s Why
- The WD-40 Company Bottoms With Reversal In Sight
- 3 Low-Cost Stock ETFs That Are Crushing It This Year
- FedEx Takes Flight; Analysts See More Gains Ahead
Receive News & Ratings for Loncar China BioPharma ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Loncar China BioPharma ETF and related companies with MarketBeat.com's FREE daily email newsletter.
